UCI Health will see you now: Welcome to our new co-workers and patients from Fountain Valley, Lakewood, Los Alamitos and Placentia-Linda! 

Creutzfeldt-Jakob Disease (vCJD) Countries of Risk

Notice about COVID-19

The UCI Health Blood Donor Center is sensitive to concerns related to COVID-19. We are therefore reaching out to our prospective blood and platelet donors.

We continue our mission of providing blood components to patients of UCI Health while maintaining safety for both patients and donors. Every day, patients rely on your continued support as a blood or platelet donor at our donor centers in Orange and Irvine.

To minimize potential COVID-19 spread, we ask that if you’ve had a recent cold or flu, to please refrain from attempting to donate until four symptom-free days have elapsed. If you’re returning from mainland China, Hong Kong, Europe, Iran, Macau or South Korea please self-defer until 28 full days have elapsed following your return to the US.

We have intensified our intervals for routine cleaning and disinfecting of common areas throughout the donor center and our staff remains diligent in using handwash and sanitizer after every donor encounter.

On behalf of the patients we serve, and with our deepest appreciation, we thank you for your continued support of our shared mission.

United Kingdom

  • Channel Islands
  • England
  • Falkland Islands 
  • Gibraltar
  • Isle of Man
  • Northern Ireland
  • Scotland
  • Wales

Europe

  • Albania
  • Austria
  • Belgium
  • Bosnia-Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Denmark
  • Finland
  • France, including its overseas departments (e.g., Martinique and others)
  • Germany
  • Greece
  • Hungary
  • Republic of Ireland
  • Italy
  • Kosovo
  • Liechtenstein
  • Luxembourg
  • Macedonia
  • Montenegro
  • Netherlands
  • Norway
  • Poland
  • Portugal, including the Azores
  • Romania
  • Serbia
  • Slovak Republic
  • Slovenia
  • Spain, including the Canary Islands and Spanish North African territories
  • Sweden
  • Switzerland

From the FDA Guidance for Industry "Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease by Blood and Blood Products," updated January 2016.

In this Section